These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38295751)

  • 1. De-escalation of loco-regional treatments: Time to find a balance.
    Gentilini OD; Cardoso MJ; Senkus E; Poortmans P
    Breast; 2024 Feb; 73():103673. PubMed ID: 38295751
    [No Abstract]   [Full Text] [Related]  

  • 2. The total incidence of loco-regional recurrence in a randomized trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial.
    Tennvall-Nittby L; Tengrup I; Landberg T
    Acta Oncol; 1993; 32(6):641-6. PubMed ID: 8260183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morbidity of local therapy for locally advanced metastatic breast cancer: an analysis of the Surveillance, Epidemiology, and End Results (SEER)-Medicare Registry.
    Fairweather M; Jiang W; Keating NL; Freedman RA; King TA; Nakhlis F
    Breast Cancer Res Treat; 2018 Jun; 169(2):287-293. PubMed ID: 29374851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis in patients diagnosed with loco-regional failure of breast cancer: 34 years longitudinal data from the Stockholm-Gotland cancer registry.
    Falato C; Taylor SK; Szulkin R; Nordblom A; Eriksson L; Sofiadis A; Fredriksson I; Hartman J; Bergh J; Foukakis T
    Breast Cancer Res Treat; 2018 Dec; 172(3):703-712. PubMed ID: 30225620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studies.
    de Bock GH; van der Hage JA; Putter H; Bonnema J; Bartelink H; van de Velde CJ
    Eur J Cancer; 2006 Feb; 42(3):351-6. PubMed ID: 16314086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
    Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Breast cancer: locoregional recurrence and subsequent disease course].
    Benz J; Juchler A
    Helv Chir Acta; 1992 May; 59(1):273-8. PubMed ID: 1526842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Loco-regional recurrence of breast cancer].
    Nielsen HM; Kamby C
    Ugeskr Laeger; 2007 Sep; 169(37):3093-6. PubMed ID: 17877957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of loco-regional recurrence and cancer-related death after breast cancer surgery.
    Rausei S; Rovera F; Dionigi G; Tornese D; Fachinetti A; Boni L; Dionigi R
    Breast J; 2010; 16 Suppl 1():S29-33. PubMed ID: 21050306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loco-regional outcomes of adjusted breast radiotherapy with conventional fractionation after breast conserving surgery: De-escalation of whole breast irradiation dose.
    Kim SW; Chun M; Oh YT; Noh OK
    Medicine (Baltimore); 2020 May; 99(18):e19916. PubMed ID: 32358358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot study to investigate the role of the 26S proteasome in radiotherapy resistance and loco-regional recurrence following breast conserving therapy for early breast cancer.
    Elfadl D; Hodgkinson VC; Long ED; Scaife L; Drew PJ; Lind MJ; Cawkwell L
    Breast; 2011 Aug; 20(4):334-7. PubMed ID: 21411324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ESR1 mutations are frequent in newly diagnosed metastatic and loco-regional recurrence of endocrine-treated breast cancer and carry worse prognosis.
    Zundelevich A; Dadiani M; Kahana-Edwin S; Itay A; Sella T; Gadot M; Cesarkas K; Farage-Barhom S; Saar EG; Eyal E; Kol N; Pavlovski A; Balint-Lahat N; Dick-Necula D; Barshack I; Kaufman B; Gal-Yam EN
    Breast Cancer Res; 2020 Feb; 22(1):16. PubMed ID: 32014063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loco-regional adjuvant radiation therapy in breast cancer patients with positive axillary lymph-nodes at diagnosis (CN2) undergoing preoperative chemotherapy and with complete pathological lymph-nodes response. Development of GRADE (Grades of recommendation, assessment, Development and Evaluation) recommendation by the Italian Association of radiation therapy and Clinical Oncology (AIRO).
    Marino L; Lancellotta V; Franco P; Meattini I; Meduri B; Bernini M; Fabi A; Corvò R; Magrini SM; Pappagallo GL; Arcangeli S; D'Angelillo RM
    Breast; 2021 Feb; 55():119-127. PubMed ID: 33445150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loco-regional recurrence following mastectomy for early breast carcinoma: efficacy of radiotherapy at the time of recurrence.
    Chaudary MA; Tong D; Millis R; Smith P; Fentiman IS; Rubens RD
    Eur J Surg Oncol; 1997 Aug; 23(4):348-53. PubMed ID: 9315067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic therapy for treating locoregional recurrence in women with breast cancer.
    Rauschecker H; Clarke M; Gatzemeier W; Recht A
    Cochrane Database Syst Rev; 2001; 2001(4):CD002195. PubMed ID: 11687148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy.
    Diab SG; Hilsenbeck SG; de Moor C; Clark GM; Osborne CK; Ravdin PM; Elledge RM
    J Clin Oncol; 1998 May; 16(5):1655-60. PubMed ID: 9586875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indicators of loco-regional recurrence in breast cancer. The South East Swedish Breast Cancer Group.
    Sundquist M; Thorstenson S; Klintenberg C; Brudin L; Nordenskjöld B
    Eur J Surg Oncol; 2000 Jun; 26(4):357-62. PubMed ID: 10873355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loco-regional recurrence and survival after wide local excision, radiotherapy and axillary clearance for early breast cancer.
    Carpenter R; Royle GT; Cross M; Hamilton C; Buchanan R; Taylor I
    J R Soc Med; 1992 Aug; 85(8):454-6. PubMed ID: 1404191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASO Author Reflections: Is Intensifying Loco-Regional Treatment in the Early Course of De Novo Stage IV Breast Cancer Reasonable?
    Soran A
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):663-664. PubMed ID: 30357577
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of loco-regional recurrence after breast-conserving surgery and radiotherapy.
    Hussian ST; Gui GP; Lee KS; Plowman PN; Gilmore OJ; Allum WH
    J R Coll Surg Edinb; 1995 Jun; 40(3):163-6. PubMed ID: 7616468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.